Fmoc-3-(4-thiazolyl)-L-alanine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-3-(4-thiazolyl)-L-alanine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fmoc-Amino Acids
Catalog number
BAT-007324
CAS number
205528-32-1
Molecular Formula
C21H18N2O4S
Molecular Weight
394.44
Fmoc-3-(4-thiazolyl)-L-alanine
IUPAC Name
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1,3-thiazol-4-yl)propanoic acid
Synonyms
Fmoc-L-Ala(4-thiazoyl)-OH; (S)-N-Fmoc-4-thiazoylalanine
Related CAS
205528-33-2 (D-isomer)
Appearance
White powder
Purity
≥ 99% (HPLC)
Density
1.378 g/cm3
Melting Point
178-181 °C
Boiling Point
647.5°C at 760 mmHg
Storage
Store at 2-8 °C
InChI
InChI=1S/C21H18N2O4S/c24-20(25)19(9-13-11-28-12-22-13)23-21(26)27-10-18-16-7-3-1-5-14(16)15-6-2-4-8-17(15)18/h1-8,11-12,18-19H,9-10H2,(H,23,26)(H,24,25)/t19-/m0/s1
InChI Key
LSBAZFASKHLHKB-IBGZPJMESA-N
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CC4=CSC=N4)C(=O)O

Fmoc-3-(4-thiazolyl)-L-alanine is an essential building block in peptide synthesis, with a variety of applications across different fields. Here are some key applications of Fmoc-3-(4-thiazolyl)-L-alanine:

Peptide Drug Development: Fmoc-3-(4-thiazolyl)-L-alanine is used in the synthesis of peptide-based drugs. Its specific side chain properties introduce unique functionalities into therapeutic peptides, enhancing their binding affinity and specificity. This allows for the development of new drugs targeting conditions like cancer, diabetes, and infectious diseases.

Protein Engineering: In protein engineering, Fmoc-3-(4-thiazolyl)-L-alanine serves as an amino acid analogue to create modified proteins with improved or novel properties. By incorporating this compound into protein sequences, researchers can investigate protein folding, stability, and functionality. This approach helps in designing proteins with tailored characteristics for industrial and therapeutic use.

Bioconjugation: Fmoc-3-(4-thiazolyl)-L-alanine is used in bioconjugation techniques to link peptides to other molecules, such as fluorescent tags, drugs, or nanoparticles. This modification enables the visualization and tracking of peptides in biological systems, enhancing the study of cellular processes and disease mechanisms. It also facilitates targeted drug delivery and diagnostic applications.

Structure-Activity Relationship Studies: Fmoc-3-(4-thiazolyl)-L-alanine is utilized in structure-activity relationship (SAR) studies to understand the impact of specific amino acid modifications on peptide function. By systematically altering peptide sequences and evaluating their biological activity, researchers can decipher the critical components for efficacy. This knowledge guides the optimization of peptides for therapeutic and research purposes.

1. 3-Methyl-1-butanol Biosynthesis in an Engineered Corynebacterium glutamicum
Shiyuan Xiao, Jingliang Xu, Xiaoyan Chen, Xiekun Li, Yu Zhang, Zhenhong Yuan Mol Biotechnol. 2016 May;58(5):311-8. doi: 10.1007/s12033-016-9929-y.
Biofuel offers a promising solution to the adverse environmental problems and depletion in reserves of fossil fuels. Higher alcohols including 3-methyl-1-butanol were paid much more attention as fuel substitute in recent years, due to its similar properties to gasoline. In the present work, 3-methyl-1-butanol production in engineered Corynebacterium glutamicum was studied. α-Ketoisovalerate decarboxylase gene (kivd) from Lactococcus lactis combined with alcohol dehydrogenase gene (adh2, adhA, and adh3) from three organisms were overexpressed in C. glutamicum. Enzymatic assay and alcohol production results showed that adh3 from Zymomonas mobilis was the optimum candidate for 3-methyl-1-butanol production in C. glutamicum. The recombinant with kivd and adh3 could produce 0.182 g/L of 3-methyl-1-butanol and 0.144 g/L of isobutanol after 12 h of incubation. Further inactivation of the E1 subunit of pyruvate dehydrogenase complex gene (aceE) and lactic dehydrogenase gene (ldh) in the above C. glutamicum strain would improve the 3-Methyl-1-butanol titer to 0.497 g/L after 12 h of incubation.
2. Engineering Corynebacterium glutamicum for isobutanol production
Kevin Michael Smith, Kwang-Myung Cho, James C Liao Appl Microbiol Biotechnol. 2010 Jul;87(3):1045-55. doi: 10.1007/s00253-010-2522-6. Epub 2010 Apr 8.
The production of isobutanol in microorganisms has recently been achieved by harnessing the highly active 2-keto acid pathways. Since these 2-keto acids are precursors of amino acids, we aimed to construct an isobutanol production platform in Corynebacterium glutamicum, a well-known amino-acid-producing microorganism. Analysis of this host's sensitivity to isobutanol toxicity revealed that C. glutamicum shows an increased tolerance to isobutanol relative to Escherichia coli. Overexpression of alsS of Bacillus subtilis, ilvC and ilvD of C. glutamicum, kivd of Lactococcus lactis, and a native alcohol dehydrogenase, adhA, led to the production of 2.6 g/L isobutanol and 0.4 g/L 3-methyl-1-butanol in 48 h. In addition, other higher chain alcohols such as 1-propanol, 2-methyl-1-butanol, 1-butanol, and 2-phenylethanol were also detected as byproducts. Using longer-term batch cultures, isobutanol titers reached 4.0 g/L after 96 h with wild-type C. glutamicum as a host. Upon the inactivation of several genes to direct more carbon through the isobutanol pathway, we increased production by approximately 25% to 4.9 g/L isobutanol in a pycldh background. These results show promise in engineering C. glutamicum for higher chain alcohol production using the 2-keto acid pathways.
3. Engineering Bacillus subtilis for isobutanol production by heterologous Ehrlich pathway construction and the biosynthetic 2-ketoisovalerate precursor pathway overexpression
Shanshan Li, Jianping Wen, Xiaoqiang Jia Appl Microbiol Biotechnol. 2011 Aug;91(3):577-89. doi: 10.1007/s00253-011-3280-9. Epub 2011 Apr 28.
In the present work, Bacillus subtilis was engineered as the cell factory for isobutanol production due to its high tolerance to isobutanol. Initially, an efficient heterologous Ehrlich pathway controlled by the promoter P(43) was introduced into B. subtilis for the isobutanol biosynthesis. Further, investigation of acetolactate synthase of B. subtilis, ketol-acid reductoisomerase, and dihydroxy-acid dehydratase of Corynebacterium glutamicum responsible for 2-ketoisovalerate precursor biosynthesis showed that acetolactate synthase played an important role in isobutanol biosynthesis. The overexpression of acetolactate synthase led to a 2.8-fold isobutanol production compared with the control. Apart from isobutanol, alcoholic profile analysis also confirmed the existence of 1.21 g/L ethanol, 1.06 g/L 2-phenylethanol, as well as traces of 2-methyl-1-butanol and 3-methyl-1-butanol in the fermentation broth. Under microaerobic condition, the engineered B. subtilis produced up to 2.62 g/L isobutanol in shake-flask fed-batch fermentation, which was 21.3% higher than that in batch fermentation.
Online Inquiry
Verification code
Inquiry Basket